Militia Capital Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
Militia Capital Management's BBC Position: Q3 2026 in Review
Militia Capital Management reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 49% in Q3 2026, selling an estimated $1.14M and leaving 23,356 shares worth $1.08M. The position accounts for 0.03% of the portfolio, ranked #202.
Militia Capital Management first reported a position in BBC in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.41M in Q2 2026. 17 funds tracked by Wall St. Rank hold BBC as of Q3 2026.
- Militia Capital Management held 23,356 shares of Virtus Biotech Clinical Trials ETF worth $1.08M as of Q3 2026.
- Militia Capital Management sold 22,307 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $1.14M.
- Virtus Biotech Clinical Trials ETF made up 0.03% of Militia Capital Management's portfolio in Q3 2026, its #202 holding.
- Militia Capital Management first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2026 and has held it in 3 quarters since.
- Militia Capital Management's Virtus Biotech Clinical Trials ETF position peaked at $2.41M in Q2 2026.
- 17 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.
Based on Militia Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.